deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03852186

Towards Personalized Medicine for OCD

Sponsor: Rigshospitalet, Denmark

Updated 6 times since 2019 Last updated: Jun 25, 2025 Started: Mar 2, 2019 Primary completion: Aug 31, 2023 Completion: Jun 25, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Obsessive-Compulsive Disorder and is currently completed. Rigshospitalet, Denmark leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotNot Yet Recruiting~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshotUnknown~Jul 2025 – present · 12 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Jul 2025 — Present [monthly]

    Completed NA

    Status: UnknownCompleted · Phase: PHASE1NA

  2. Sep 2024 — Jul 2025 [monthly]

    Unknown PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown StatusUnknown

  4. Nov 2022 — Jul 2024 [monthly]

    Unknown Status PHASE1

    Status: Not Yet RecruitingUnknown Status

  5. Jan 2021 — Nov 2022 [monthly]

    Not Yet Recruiting PHASE1

Show 1 earlier version
  1. Mar 2019 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Rigshospitalet, Denmark
Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations